Assessment of contribution of BCRP to intestinal absorption of various drugs using portal‐systemic blood concentration difference model in mice
Abstract Prediction of the intestinal absorption of new chemical entities (NCEs) is still difficult, in part because drug efflux transporters, including breast cancer resistance protein (BCRP) and P‐glycoprotein (P‐gp), restrict their intestinal permeability. We have demonstrated that the absorptive...
Saved in:
Main Authors: | Iichiro Kawahara (Author), Satoyo Nishikawa (Author), Akira Yamamoto (Author), Yusuke Kono (Author), Takuya Fujita (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
by: Yusuke Kono, et al.
Published: (2021) -
Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats
by: Tammam Alama, et al.
Published: (2019) -
Enhanced Intestinal Absorption of Insulin by Capryol 90, a Novel Absorption Enhancer in Rats: Implications in Oral Insulin Delivery
by: Hiroki Ukai, et al.
Published: (2020) -
Intestinal Ischemia-Reperfusion Increases Efflux for Uric Acid Via Paracellular Route in the Intestine, but Decreases that Via Transcellular Route Mediated by BCRP
by: Jiro Ogura, et al.
Published: (2012) -
A novel biosensor based on intestinal 3D organoids for detecting the function of BCRP
by: Lei Zhang, et al.
Published: (2017)